India's office leasing jumps 40 pc in H1 2025, new supply jumps 25 pc: Report
According to data compiled by Anarock Research, net office absorption grew from around 19.08 million sq. ft. in H1 2024 to approximately 26.8 million sq. ft. in H1 2025.
New office supply also increased by 25 per cent during the same period, reaching nearly 24.51 million sq. ft.
Experts say the strong office market performance reflects India's steady economic growth and its rising global profile as a business destination.
Peush Jain, Managing Director, Commercial Leasing & Advisory at Anarock Group, said the country continues to attract large-scale office leasing by global capability centres (GCCs) and US-based corporates.
He also noted that India's economic stability stands in contrast to policy uncertainty in the US, making it an increasingly attractive destination for long-term investments.
Bengaluru led the leasing activity with around 6.55 million sq. ft. of office space absorbed in H1 2025 -- a 64 per cent increase compared to 4 million sq. ft. in the same period previous year.
Pune stood out with the highest annual growth in net absorption, soaring by 188 per cent to 3.8 million sq. ft., up from 1.32 million sq. ft. the previous year.
Kolkata, however, was the only city among the top seven to see a decline in leasing, dropping 51 per cent to just 0.45 million sq. ft.
In terms of new office space completions, Bengaluru again took the lead by adding approximately 6.91 million sq. ft. in H1 2025, a 26 per cent rise from the previous year.
Pune posted an exceptional 533 per cent jump in new supply, going from just 0.9 million sq. ft. in H1 2024 to over 5.7 million sq. ft. this year, the report stated.
Sector-wise, the IT/ITeS sector continued to drive demand, accounting for 29 per cent of overall office leasing.
This was followed by the coworking sector at 22 per cent and BFSI at 18 per cent.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
2 minutes ago
- Business Standard
Eris Lifesciences to tap Rs 5,000-cr insulin and semaglutide market in FY26
Ahmedabad-based Eris Lifesciences is looking to tap opportunities in the nearly Rs 5,000-crore Indian insulin market after Danish drugmaker Novo Nordisk announced the withdrawal of its insulin products from the market in April this year. 'We expect that Novo's cartridge inventory in the market will run out by October 2025. So this market opportunity is something that one can start monetising from the November–December time frame,' the company's executive director and chief executive officer (CEO), Krishnakumar Vaidyanathan, told Business Standard. He added that the timing fits Eris' plans, as the cartridge filling capability of its Bhopal unit will start becoming operational from January. Vial manufacturing has already been commissioned at the unit, with the company creating a strategic stock of insulins. This comes at a time when Eris is already the largest domestic player in insulins. The company had acquired the India formulations business of Biocon Biologics last year — including established insulin brands Basalog and Insugen. 'Before the Biocon deal, we had a couple of homegrown insulin brands in the market, which did a combined Rs 60 crore in revenue last year. Basalog and Insugen had combined revenues of Rs 200 crore at the time of acquisition,' he said. He added that, with this, the company's insulin franchise has become significantly larger, with a 10 per cent market share. Eris is also among the prominent drugmakers looking to roll out generic versions of the blockbuster molecule semaglutide once its patent expires around March next year. Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist used as an active pharmaceutical ingredient in medications for obesity management and Type-II diabetes. According to Eris' investor presentation for the June quarter of 2025–26 (Q1FY26), the company is on track to be among the first launches in India in March 2026. The company has initiated validation of synthetic semaglutide cartridges at its European Union (EU)-approved AMD injectables site. 'We are also planning the validation of the recombinant semaglutide in our Bhopal plant later this year,' he added. As far as the go-to-market strategy is concerned, the company said it is already in a strong position because of its dominant presence in insulins and prior presence in the GLP market with the launch of liraglutide in September last year. For Q1FY26, Eris Lifesciences recorded a 40 per cent year-on-year (Y-o-Y) rise in consolidated profit after tax (PAT) to Rs 125 crore. Revenue rose to Rs 773 crore during the June quarter against Rs 720 crore in the year-ago period.
&w=3840&q=100)
Business Standard
2 minutes ago
- Business Standard
Assetz acquires 11.5 acres in Bengaluru for ₹1,400 crore housing project
Bengaluru-based real estate developer Assetz has acquired an 11.5-acre land parcel on Old Madras Road (OMR)–Hoskote Highway in East Bengaluru to develop a luxury residential community with an estimated gross development value (GDV) exceeding ₹1,400 crore. The strategic move is backed by Motilal Oswal Alternates (MOA). The company stated that the acquisition includes a joint development component with Vanshee Builders & Developers Pvt Ltd. The upscale residential project, featuring highway-facing support amenities, will span 1.4 million square feet of saleable built-up area (SBA) and comprise approximately 800 units. This move further strengthens Assetz's position in East Bengaluru — a market where it has already made a mark with projects such as Marq, Bloom & Dell, Sun & Sanctum, 66, and Shibui. 'Strategic land acquisition has always been fundamental to our development approach, laying the groundwork well before execution begins. In the past two years alone, we have secured a pipeline of 17 million square feet across 19 projects with the potential to deliver 9,000 homes. With 10 launches this year, we are committed to delivering homes that offer long-term value to our buyers and communities alike,' said Sunil Pareek, executive director, Assetz. In July, Motilal Oswal Alternates closed its sixth real estate fund with a corpus of ₹2,000 crore. Anand Lakhotia, managing director and co-head (real estate) at Motilal Oswal Alternates, commented, 'We are well-positioned to support quality land acquisitions. This association reflects our belief in Assetz's vision of a professional residential platform with established execution capabilities. Their emphasis on good governance, supported by a steady track record, is in line with our strategy of investing in top-performing developers.' Since 2006, Assetz has delivered 20 residential and commercial projects totalling approximately 15 million square feet. In the residential segment, the company has continued to scale, building a portfolio of 46 projects — delivered, launched, and under approval — with a cumulative development potential of 45 million square feet.
Mint
2 minutes ago
- Mint
India-UK trade deal: India's seafood exports to rise threefold; fisherfolk to get better price as export duty scrapped
Seafood exports from India to the United Kingdom (UK) are poised for a significant boost, with industry leaders predicting a threefold jump in the coming years. This surge is expected to be a direct result of a new trade agreement between the two nations, which will eliminate the current 8.9 per cent export duty on fisheries products, PTI reported. The UK is a major importer of seafood from across the world, with a market valued at $5.4 billion annually. Gujarat-based exporter Jagdish Fofandi, the former vice president of Marine Products Export Development Authority (MPEDA), said the relief in export duty would take India's seafood export to the UK from current levels of ₹ 1,000 crore to nearly ₹ 3,000 crore in three years. India's current share in this basket is just 2.2 per cent, which comes to around ₹ 1,000 crore at present. 'With the removal of the export duty, Indian seafood items will become cheaper by nearly 8 to 9 per cent for the buyers in the UK, making Indian products more competitive in comparison to other countries," Fofandi told PTI. "We are assuming that in the next three years, there is a potential growth of 300 per cent. Thus, I am seeing that our export will go up from the current level of ₹ 1,000 crore to ₹ 3,000 crore,' he said. Gujarat, with its extensive coastline of nearly 2,300 kilometres, is considered one of the key states contributing to India's seafood exports. Industry leaders believe that the increase in India's exports will also help Gujarat-based fishermen, exporters and the entire ecosystem attached with this industry: Shrimp makes up 70 per cent of India's total seafood export basket. However, it is facing challenges from US and other markets at present, said Fofandi. He further added that the new UK market will absorb some of the shock, particularly helping the shrimp farming industry of South Gujarat. While South Gujarat is more into shrimp farming, the coastline of Saurashtra region is known for its sea fish exports. Certain varieties of fish exported from that region have already become popular among Indians and Chinese settled in the UK. 'This trade agreement will eventually help fishermen in getting better prices for the catch,' said Ketan Suyani, Gujarat-based regional president of SEAI. At present, Gujarat's fisheries export is roughly around ₹ 5,000 crore. Of these, entire Europe accounts for nearly 40 per cent while the remaining 60 per cent goes to the Gulf, China and other Far-east countries, said Suyani. "This trade agreement will eventually benefit Gujarat fishermen because the demand for Indian seafood products will increase after the duty reduction. Fishermen will get better prices with the increase in export quantity," he said. In July 2025, India and the United Kingdom signed the Comprehensive Economic and Trade Agreement (CETA), a bilateral free trade agreement, said a news report. CETA provides duty-free access to 99 per cent of India's exports to the UK, which covers nearly 100 per cent of the trade value. This includes labour-intensive sectors such as textiles, leather, marine products, gems and jewellery, and toys as well as high-growth sectors like engineering goods, chemicals, and auto components.
